Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (121-130 of 1,192) with videos related to

Pageof 120
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|December 9, 2010
Pharmaceutical approval updateMarvin M Goldenberg
Progress in Clinical and Biological Research|January 1, 1989
Imaging and therapy of cancer with radiolabeled monoclonal antibodiesD M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
Pharmaceutical approval updateMarvin M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 16, 2013
Pharmaceutical approval updateMarvin M Goldenberg
Clinical Therapeutics|July 13, 2000
Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritisM M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Introduction to the Seventh Conference on Radioimmunodetection and Radioimmunodetection and Radioimmunotherapy of CancerD M Goldenberg
Clinical Therapeutics|November 28, 2017
Choosing Dipeptidyl Peptidase-4 Inhibitors, Sodium-glucose Cotransporter-2 Inhibitors, or Both, as Add-ons to Metformin: Patient Baseline Characteristics Are CrucialRonald M Goldenberg
Critical Reviews in Oncology/Hematology|June 22, 2001
The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapyD M Goldenberg
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1970
Radiopotentiating action of 1-beta-D-arabinofuranosylcytosine in a xenografted human colonic carcinomaD M Goldenberg
Experientia|August 15, 1970
Reduced lymphatic drainage from hamster cheek pouch: a proposed explanation of its immunologically privileged characterD M Goldenberg
Pageof 120

Showing results (121-130 of 1,192) with videos related to

Sort By:
Pageof 120
P & T : a Peer-Reviewed Journal for Formulary Management|December 9, 2010
Pharmaceutical approval updateMarvin M Goldenberg
Progress in Clinical and Biological Research|January 1, 1989
Imaging and therapy of cancer with radiolabeled monoclonal antibodiesD M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|May 4, 2013
Pharmaceutical approval updateMarvin M Goldenberg
P & T : a Peer-Reviewed Journal for Formulary Management|January 16, 2013
Pharmaceutical approval updateMarvin M Goldenberg
Clinical Therapeutics|July 13, 2000
Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritisM M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Introduction to the Seventh Conference on Radioimmunodetection and Radioimmunodetection and Radioimmunotherapy of CancerD M Goldenberg
Clinical Therapeutics|November 28, 2017
Choosing Dipeptidyl Peptidase-4 Inhibitors, Sodium-glucose Cotransporter-2 Inhibitors, or Both, as Add-ons to Metformin: Patient Baseline Characteristics Are CrucialRonald M Goldenberg
Critical Reviews in Oncology/Hematology|June 22, 2001
The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapyD M Goldenberg
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1970
Radiopotentiating action of 1-beta-D-arabinofuranosylcytosine in a xenografted human colonic carcinomaD M Goldenberg
Experientia|August 15, 1970
Reduced lymphatic drainage from hamster cheek pouch: a proposed explanation of its immunologically privileged characterD M Goldenberg
Pageof 120